Technology | 2019.02.21
ViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy System
CLEVELAND, Feb. 21, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), announced today that the company received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market new soft tissue visualization capabilities for its MRIdian system. The new upgradable capabilities...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]-therapy-system-300799384.html
